1. Home
  2. BNZI vs ALZN Comparison

BNZI vs ALZN Comparison

Compare BNZI & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$3.25

Market Cap

5.7M

Sector

N/A

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.23

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNZI
ALZN
Founded
2016
2016
Country
United States
United States
Employees
34
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
4.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BNZI
ALZN
Price
$3.25
$1.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$24.00
$28.00
AVG Volume (30 Days)
319.0K
143.2K
Earning Date
05-14-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.28
N/A
Revenue Next Year
$0.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.84
52 Week High
$8.10
$3.60

Technical Indicators

Market Signals
Indicator
BNZI
ALZN
Relative Strength Index (RSI) 51.90 50.68
Support Level $2.80 $1.04
Resistance Level $3.99 $1.25
Average True Range (ATR) 0.25 0.11
MACD 0.00 -0.01
Stochastic Oscillator 73.23 42.10

Price Performance

Historical Comparison
BNZI
ALZN

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: